25 February 2016
Organised by:
SCI's Young Chemists' Panel
Queen Mary University of London, UK
This event is no longer available for registration.
Following on from the success of the 2011 "International Year of Chemistry" and the 2013 "Discovering Chemistry" public lecture series, the SCI Young Chemists' Panel is pleased to announce the "3rd Discovering Chemistry Lecture series" hosted at Universities around the country in 2016.
The lectures will be given by industrial and academic experts who will illustrate how chemistry impacts our everyday lives in Britain and worldwide. The series aims to highlight how diverse the field of chemistry is and to provide a brief introduction to a few of the wide range of applications and cutting-edge technologies which fall under the chemistry umbrella. Titles such as "Extreme Drug Discovery", "Global Warming - How can Green Chemistry Help" and "Magic, Folk Medicine, Drugs and Chemistry" are certain to attract interested parties at all venues.
SCI accessibility grants are available to support SCI members with disabilities, long term health conditions, those who require a carer, and members who are nursing parents to attend SCI events. Download an application form to apply for a grant.
Queen Mary University of London
G.O. Jones Lecture Theatre
Department of Physics
Queen Mary University of London
Mile End Road
London
E1 4NS
UK
Conference Team
Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations
SCI Members attending this meeting are able to claim CPD points.
This lecture will describe how molecules isolated from Nature have played a key role in many human activities from magic through to drugs. It will illustrate how chemistry and chemists have developed some of the modern medicines that society now depends on an which have enhanced life expectancy so spectacularly in the last 100 years.
Professor Keith Jones works to design, synthesise and develop potential drug molecules to inhibit proteins or signalling pathways relevant in cancer. He has held positions within the Royal Society of Chemistry and has helped organise and run international meetings on medicinal chemistry.
He currently works at the Institute of Cancer Research.
Liz Jones, UCB
Mark Betson, Peakdale Molecular
Mike Lainchbury, Charles River Laboratories
Chris Jones, Queen Mary University of London
Danny Mortimer, Johnson Matthey